Who owns Profound Med Corp?
- Ticker: PROF
- CUSIP Number: 74319b502
Tip: Access positions for across all investors
Analyze quarterly positions in Profound Med Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Profound Med Corp stock
Who bought or sold Profound Med Corp this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Gagnon Securities | 1.5M | $13M | -3% | Dec 2023 |
|
Fil | 1.4M | $11M | 12% | Mar 2024 |
|
Letko, Brosseau & Associates | 1.2M | $9.9M | 5% | Mar 2024 |
|
Timelo Investment Management | 856k | $7.3M | 27% | Mar 2024 |
|
Gagnon Advisors | 679k | $5.8M | 0% | Dec 2023 |
|
AIGH Capital Management | 647k | $5.5M | 0% | Mar 2024 |
|
Raymond James Financial Services Advisors | 626k | $5.3M | 0% | Mar 2024 |
|
Royce & Associates | 564k | $4.8M | 0% | Mar 2024 |
|
Rosalind Advisors | 533k | $4.5M | 0% | Mar 2024 |
|
Royal Bank of Canada | 400k | $3.8M | 0% | Mar 2024 |
|
Bank of America Corporation | 204k | $1.7M | -2% | Mar 2024 |
|
Ardsley Advisory Partners | 145k | $1.2M | 100% | Mar 2024 |
|
Bleichroeder | 133k | $1.1M | 100% | Dec 2023 |
|
National Bank Of Canada /fi/ | 127k | $1.0M | -1% | Dec 2023 |
|
Zweig-DiMenna Associates | 104k | $889k | -20% | Mar 2024 |
|
Thompson Davis & Co | 69k | $586k | 0% | Mar 2024 |
|
Raymond James & Associates | 50k | $426k | -24% | Mar 2024 |
|
Chilton Investment | 30k | $256k | 200% | Mar 2024 |
|
Susquehanna International | 26k | $225k | 161% | Mar 2024 |
|
Citadel Advisors | 21k | $182k | -28% | Mar 2024 |
|
MTM Investment Management | 20k | $167k | 0% | Mar 2024 |
|
Goldman Sachs Group | 17k | $143k | -25% | Mar 2024 |
|
TD Waterhouse Canada | 15k | $167k | -7% | Mar 2024 |
|
Silvercrest Asset Management Group | 15k | $128k | 100% | Mar 2024 |
|
Geode Capital Management | 14k | $120k | 21% | Mar 2024 |
|
Cetera Investment Advisers | 12k | $100k | 100% | Mar 2024 |
|
Bank Of Montreal | 12k | $98k | -4% | Mar 2024 |
|
Wells Fargo & Company | 4.8k | $41k | 42% | Mar 2024 |
|
Morgan Stanley | 4.5k | $39k | -41% | Mar 2024 |
|
SOA Wealth Advisors | 4.0k | $34k | 0% | Mar 2024 |
|
Wetzel Investment Advisors | 2.0k | $16k | 0% | Mar 2024 |
|
Advisor Group Holdings | 771.00 | $6.6k | -28% | Mar 2024 |
|
Federation des caisses Desjardins du Quebec | 740.00 | $8.1k | 100% | Mar 2024 |
|
UBS Group | 645.00 | $5.5k | 100% | Mar 2024 |
|
Harbor Investment Advisory | 250.00 | $2.1k | 0% | Mar 2024 |
|
Cape Investment Advisory | 231.00 | $2.0k | 100% | Dec 2023 |
|
Tower Research Capital | 103.00 | $879.002000 | 100% | Mar 2024 |
|
CWM | 100.00 | $1.0k | 0% | Mar 2024 |
|
Simplex Trading | 87.00 | $0 | 100% | Mar 2024 |
|
Hanson McClain Advisors | 48.00 | $410.001600 | 100% | Mar 2024 |
|
Parallel Advisors | 30.00 | $255.999000 | 0% | Mar 2024 |
|
Who sold out of Profound Med Corp?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Worth Venture Partners | Dec 2023 | 161k | $1.4M |
Kepos Capital | Dec 2023 | 100k | $849k |
Financial Network Investment Corporation | Sep 2023 | 12k | $118k |
Schonfeld Strategic Advisors | Dec 2023 | 11k | $95k |
Levin Capital Strategies | Dec 2023 | 10k | $85k |
FNY Investment Advisers | Dec 2023 | 8.0k | $67k |
Jpmorgan Chase & Co | Dec 2023 | 1.5k | $13k |
Group One Trading | Sep 2023 | 99.00 | $1.0k |